Print Friendly, PDF & Email

NCT/Study#

NCT02861573 /

MK3475-365

Phase Ib/II Trial Of Pembrolizumab (MK-3475) Combination Therapies In Metastatic Castration-Resistant Prostate Cancer (Mcrpc)

DISEASE GROUP:

Genito-Urinary

current phase:

Phase I/II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587